ArrowMark Colorado Holdings’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.75M | Buy |
585,397
+143,806
| +33% | +$2.15M | 0.16% | 135 |
|
|
2025
Q1 | $5.17M | Sell |
441,591
-7,010
| -2% | -$82.1K | 0.08% | 174 |
|
|
2024
Q4 | $10.3M | Buy |
448,601
+62,136
| +16% | +$1.42M | 0.14% | 135 |
|
|
2024
Q3 | $16.2M | Hold |
386,465
| – | – | 0.21% | 107 |
|
|
2024
Q2 | $14.1M | Sell |
386,465
-51,073
| -12% | -$1.86M | 0.17% | 116 |
|
|
2024
Q1 | $22.3M | Sell |
437,538
-87,991
| -17% | -$4.48M | 0.25% | 94 |
|
|
2023
Q4 | $10.2M | Buy |
+525,529
| New | +$10.2M | 0.11% | 143 |
|